- Home
- »
- Medical Devices
- »
-
Artificial Tendons And Ligaments Market Size Report, 2033GVR Report cover
Artificial Tendons And Ligaments Market (2026 - 2033)
Size, Share & Trends Analysis Report By Application (Knee Injuries, Shoulder Injuries, Foot & Ankle Injuries), By End Use (Hospitals, Outpatient Facilities), By Region, And Segment Forecasts
Market Size, 2025
$43.3MMarket Estimate, 2026
$48.2MMarket Forecast, 2033
$103.3MCAGR, 2026–2033
11.5%Artificial Tendons And Ligaments Market Summary
The global artificial tendons and ligaments market size was valued at USD 43.3 million in 2025 and is projected to grow from USD 48.2 million in 2026 to USD 103.3 million by 2033, at a CAGR of 11.5% from 2026 to 2033. Europe dominated the market, accounting for a revenue share of 49.0% in 2025. The rising number of sports injuries, increased spending on orthopedic solutions, and growing interest in minimally invasive surgery are among the factors driving worldwide market growth.
Source: Grand View Research, IR Documents, Primary Interviews, Paid DatabasesTo learn more about this report,Download Free Sample Report
Key Market Trends & Insights
- By application: The knee injuries segment held the largest market share of around 45.0% in 2025.
- By end-use: The hospital segment held the largest market share of approximately 72.0% in 2025.
Regional Highlights
- Largest regional market: Europe (49.0% revenue share, 2025)
- Fastest-growing regional market: Asia Pacific (highest CAGR, 2026-2033)
Market Size & Forecast
- Market size in 2025: USD 43.3 Million
- Estimated market size in 2026: USD 48.2 Million
- Projected market size by 2033: USD 103.3 Million
- CAGR (2026-2033): 11.5%
Prism AI by Grand View Research Free to tryAsk a question about the artificial tendons and ligaments marketTry asking✓Every figure cited from GVR research Prefer the report? Download free sample →The increasing incidence of sports-related injuries globally is a major contributor to the market growth, as the demand for effective repair solutions continues to rise. Moreover, technological advancements in biomaterials and surgical techniques are enhancing the performance and reliability of artificial tendons and ligaments, expanding their applications in various medical fields.
As older adults are more susceptible to musculoskeletal disorders, the demand for tendon and ligament replacements is increasing. The shift towards minimally invasive surgical procedures, which offer shorter recovery times and lower complication rates, is driving the adoption of artificial tendons and ligaments. The improved healthcare infrastructure in emerging economies is also contributing to market expansion, as patients gain access to specialized orthopedic care.
The market is also driven by patient preference for advanced treatment options. Increased awareness and preference for innovative, durable solutions are driving patient demand for artificial tendons and ligaments. Companies are actively expanding their global footprint, leveraging innovation to drive growth. For instance, in July 2024, Enovis expanded its presence in South Africa by combining the strengths of Mathys Medical, LimaCorporate, and P&R to offer a broader range of medical technology solutions.
The development of synthetic ligament grafts that can connect with natural bones and provide knee support is a significant area of focus, with research institutions and companies working to create materials with high tensile strength, abrasion resistance, and no immune response. By addressing these challenges and opportunities, the industry can unlock its full potential and provide patients with more effective treatment options.
Analyst Perspective
The global artificial tendons and ligaments industry is driven by the rising number of sports injuries and joint disorders among the aging population, as well as patients' preference for quick recovery. Further, expansion of healthcare infrastructure and corporate expansion also create demand for this market. However, the market faces challenges due to the risk of immune rejection of the body, which can lead to implant failure, and the technical challenges of synthetic grafts. To overcome these hurdles, an opportunity has emerged for advanced research into developing new synthetic grafts with high tensile strength, and technological advances can help lead the market.
Application Insights
The knee injuries segment led the market with the largest revenue share of approximately 45.0% in 2025, due to the rise in incidents of Anterior Cruciate Ligament (ACL) injuries. Most ACL tears occur in sports that involve sudden movements, such as jumping, acceleration, and deceleration. According to Corewell Health, over 70% of ACL tears occur without physical contact or impact. Also, according to a 2026 NIH study, video analyses indicate that approximately 90% of injuries occur during pressing, cutting, or landing tasks. With consistent growth in track and field participation and the promotion of physical sports through frequent tournaments and local and international leagues, there has been a rise in knee injuries among athletes and sportspersons.
The foot and ankle injuries segment is expected to grow at the fastest CAGR of approximately 11.5% during the forecast period. The demand for artificial tendons and ligaments for foot and ankle injuries is rising, driven by the growth of sports-related activities and accidents. Although less prevalent than knee injuries, foot and ankle injuries are experiencing increased demand due to improved surgical success rates and prosthetic technologies.
End Use Insights
The hospitals segment led the market with the largest revenue share of approximately 72.0% in 2025. The growing number of tendon repairs done in outpatient facilities with short hospital stays is fueling the use of synthetic tendons and ligaments. Surgeons require tendon grafts as a necessary device for repairing severe injuries. Medical facilities, such as clinics and hospitals, provide various reconstruction and repair services that also influence market growth.
The outpatient facilities segment is projected to grow at the fastest CAGR of approximately 12.0% over the forecast period. More recent surgical procedures for tendon and ligament repair are minimally invasive, resulting in shorter recovery periods and enabling more outpatient surgeries. Outpatient surgeries are less expensive than hospital-based surgeries, which is why they attract the attention of patients and insurance companies. Outpatient centers offer many benefits, including shorter wait times and possibly a better healing environment than in the hospital.
Regional Insights
The artificial tendons and ligaments market in North America is anticipated to witness at a significant CAGR during the forecast period. The availability of more tendon replacement options, combined with regulatory approvals, is attracting consumers to artificial tendons and ligaments. The growing elderly population, increasing use of minimally invasive surgeries, and favorable reimbursement policies will drive the growth of the regional industry, further solidified by a robust healthcare infrastructure.
U.S. Artificial Tendons and Ligaments Market Trends
The artificial tendons and ligaments market in the U.S. accounted for the largest market revenue share of above 91.0% in North America in 2025. The country’s prominent culture of sports participation leads to a high incidence of ligament tears and tendon ruptures, primarily affecting young athletes. This demand drives the need for repair solutions, including artificial tendons and ligaments. The U.S. healthcare system’s substantial investment in orthopedic solutions, particularly in procedures such as tendon and ligament repair, further underscores the market’s potential.
Europe Artificial Tendons and Ligaments Market Trends
Europe dominated the global artificial tendons and ligaments market with the largest revenue share of approximately 49.0% in 2025. The increase in government efforts to encourage sports, the growth of events showcasing the latest sports technologies, the rise in sports injuries and knee replacements, the expansion of the medical device sector, the affordability of medical devices, and partnerships among various entities are all contributing to market growth in the region.
To learn more about this report,Download Free Sample Report
The artificial tendons and ligaments market in the UK is expected to grow at a rapid CAGR during the forecast period. The UK has a strong sporting culture, leading to a higher number of sports-related injuries that can damage tendons and ligaments. The UK healthcare system is increasingly adopting minimally invasive techniques, which are well-suited for implanting artificial tendons and ligaments.
Asia Pacific Artificial Tendons and Ligaments Market Trends
The artificial tendons and ligaments market in the Asia Pacific is projected to grow at the fastest CAGR of approximately 12.0% over the forecast period. Significant investments in R&D by global market leaders and increasing public awareness about artificial tendons, ligaments, and ACL surgeries are propelling this sector. It is predicted that China and India will grow rapidly, although Australia & Japan have well-developed markets in this segment. Arthroscopic procedures, such as those in the knee, ankle, and shoulder, require autologous and allogenic ligaments.
The China artificial tendons and ligaments market is expected to grow rapidly over the forecast period. China’s rapidly aging population, characterized by a high prevalence of tendon and ligament degeneration, drives demand for surgeries using artificial implants. The growing middle class, with increasing disposable income, is more likely to opt for advanced medical treatments, such as artificial tendons and ligaments, fueling the market’s growth.
Key Artificial Tendons and Ligaments Company Insights
Some key companies in the artificial tendons and ligaments industry include COUSIN SURGERY, Smith+Nephew, Zimmer Biomet, Xiros Ltd. (Neoligaments), and Orthomed, among others. Companies are implementing various strategic actions, such as consolidations, takeovers, and collaborations with other prominent firms.
- Cousin Surgery, a French medical device company, which offers implant solutions for visceral and spinal surgery. The company partners with surgeons, universities, and research labs to develop new devices. The company’s spinal surgery offerings include the BDyn and IntraSPINE devices, providing alternative surgical solutions that promote patient mobility and reduce postoperative pain.
- Smith+Nephew is a global medical technology company, headquartered in the UK, that offers advanced wound management, sports medicine, and orthopedic reconstruction. Its sports medicine division offers a range of artificial ligaments and tendons, including the LARS system, used in various surgical procedures to treat sports-related injuries and degenerative conditions.
Key Artificial Tendons And Ligaments Companies
The following key companies have been profiled for this study on the global artificial tendons and ligaments market:
-
COUSIN SURGERY
-
Smith+Nephew
-
Zimmer Biomet
-
Xiros Ltd. (Neoligaments)
-
Orthomed
-
Shanghai PINE&POWER Biotech
-
Arthrex Inc.
-
Corin Group
-
Enovis Corporation (Mathys AG Bettlach)
-
Stryker
-
GROUP FH ORTHO
Recent Developments
- In March 2025. Zimmer Biomet, a global medical technology leader, announced it is diversifying its portfolio of orthopedic and musculoskeletal innovations at the American Academy of Orthopedic Surgeons (AAOS) annual meeting.
- In July 2024, Stryker acquired Artelon, which specializes in soft tissue fixation products, enhancing its portfolio and competitive edge in the foot and ankle and sports medicine segments.
- In May 2024, Enovis opened a new medical device production plant in San Daniele, Italy, in May 2024, doubling production capacity and creating over 100 jobs, solidifying its position in the industry.
- In February 2024, Smith+Nephew unveiled its expanded Sports Medicine portfolio at the 2024 AAOS Annual Meeting, featuring the CARTIHEAL AGILI-C Cartilage Repair Implant and REGENETEN Bioinductive Implant, demonstrating its leadership in enabling biological healing.
- In January 2024, Arthrex Inc., a pioneer in minimally invasive surgical technology, previously launched TheNanoExperience.com, a patient-centered website highlighting the benefits of Nano arthroscopy, an innovative orthopedic technique that enables rapid recovery and reduced pain.
Artificial Tendons and Ligaments Market Report Scope
Report Attribute
Details
Market size in 2025
USD 43.3 million
Estimated market size in 2026
USD 48.2 million
Projected market size by 2033
USD 103.3 million
Growth rate
CAGR of 11.5% from 2026 to 2033
Base year for estimation
2025
Historical data
2021 – 2024
Forecast period
2026 – 2033
Quantitative units
Revenue in USD million/billion, and CAGR from 2026 to 2033
Report coverage
Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments covered
Application, end use, region
Regional scope
North America; Europe; Asia Pacific; Latin America; Middle East & Africa
Country scope
U.S.; Canada; Mexico; UK; Germany; France; Italy; Spain; Denmark; Norway; Sweden; China; Japan; India; Australia; South Korea; Thailand; Brazil; Argentina; South Africa; Saudi Arabia; UAE; Kuwait
Key companies profiled
COUSIN SURGERY; Smith+Nephew; Zimmer Biomet; Xiros Ltd. (Neoligaments); Orthomed; Shanghai PINE&POWER Biotech; Arthrex Inc.; Corin Group; Enovis Corporation (Mathys AG Bettlach); Stryker; GROUP FH ORTHO
Customization scope
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options
Avail of customized purchase options to meet your exact research needs. Explore purchase options
Global Artificial Tendons and Ligaments Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global artificial tendons and ligaments market report based on application, end use, and region:
-
Application Outlook (Revenue, USD Million, 2021 - 2033)
-
Knee Injuries
-
Shoulder Injuries
-
Foot and Ankle Injuries
-
Other Applications
-
-
End-use Outlook (Revenue, USD Million, 2021 - 2033)
-
Hospitals
-
Outpatient Facilities
-
-
Regional Outlook (Revenue, USD Million, 2021 - 2033)
-
North America
-
U.S.
-
Canada
-
Mexico
-
-
Europe
-
UK
-
Germany
-
France
-
Italy
-
Spain
-
Denmark
-
Sweden
-
Norway
-
-
Asia Pacific
-
China
-
Japan
-
India
-
Australia
-
South Korea
-
Thailand
-
-
Latin America
-
Brazil
-
Argentina
-
-
Middle East and Africa
-
South Africa
-
Saudi Arabia
-
UAE
-
Kuwait
-
-
Frequently Asked Questions About This Report
The global artificial tendons and ligaments market size was valued at USD 43.3 million in 2025 and is estimated at USD 48.2 million for 2026.
The global artificial tendons and ligaments market is expected to grow at a CAGR of 11.5% from 2026 to 2033, reaching USD 103.3 million.
Europe dominated with approximately 49.0% revenue share in 2025.
The knee injury segment accounted for the largest revenue share of approximately 45.0% in 2025.
Key players in the market include COUSIN SURGERY; Smith+Nephew; Zimmer Biomet; Xiros Ltd. (Neoligaments); Orthomed; Shanghai PINE&POWER Biotech; Arthrex Inc.; Corin Group; Enovis Corporation (Mathys AG Bettlach); Stryker; GROUP FH ORTHO, and others.
About the Author(s)
Medical Devices Research Team
Healthcare · Medical DevicesThis report was authored by the medical devices research team at Grand View Research - comprising two research analysts, one senior research analyst, and one industry expert - with specialized expertise in the medical devices segment of the healthcare industry. All findings are based on proprietary healthcare databases, executive interviews, and regulatory analysis, subject to internal peer review prior to publication.
Last Updated:
Speak to Analyst
Customize this report to your needs - add regions, segments, or data points, with 20% free customization.
Or view our licence options:
ISO 9001:2015 & 27001:2022 Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.